China FDA Poised To Issue Supplementary Regulations
This article was originally published in The Silver Sheet
Executive Summary
More than 10 regulations pending from China FDA will target most aspects of a device’s lifecycle, ranging from clinical study requirements, regulatory approval, manufacturing and quality assurance, through to post-market surveillance.